On February 7, 2024, Indonesia requested consultations with the European Union with respect to (i) the definitive anti-dumping measures on imports of fatty acid from Indonesia; (ii) the investigation leading to the imposition of these measures; and (iii) the methodology applied by the European Union in anti-dumping investigations (including in the investigation on imports of fatty acid from Indonesia) for constructing normal value based on product control numbers (PCN)-specific costs and profit data.
Indonesia claimed that definitive anti-dumping measures on imports of fatty acid from Indonesia, and the investigation leading to their imposition appear to be inconsistent with:
• Articles 1, 2.2, 2.2.2, 2.4.1, 3.1, 3.4, 5.3, 5.4, 5.6, 5.8, 9.2, and 9.3 of the Anti-Dumping Agreement; and
• Articles X:3(a) and VI of the GATT 1994.
Indonesia also claimed that the methodology applied by the European Union in anti-dumping investigations for constructing normal value based on PCN-specific costs and profit data appears to be inconsistent with:
• Articles 2.2 and 2.2.2 of the Anti-Dumping Agreement; and
• Article X:3(a) of the GATT 1994.
On November 14, 2024, Indonesia requested the establishment of a panel. At its meeting on November 25, 2024, the DSB deferred the establishment of a panel.
At its meeting on December 18, 2024, the DSB established a panel. Australia, Brazil, Canada, China, Japan, Russia, Singapore, Türkiye, Ukraine, the United Kingdom and the United States, reserved their third-party rights.
Following the agreement of the parties, the panel was composed on April 11, 2025.
| Brief Date | Brief Description |
|---|---|
| 08/12/2025 | U.S. Third-Party Submission |
